Evidence-based approach to harmonised reference intervals

Clinica Chimica Acta

Volumn 432, Issue , 2014, Pages 99-107

  Koerbin, Gus ^a,b   Sikaris, Ken Andrew ^c   Jones, Graham Ross Dallas ^d   Ryan, Julie ^e   Reed, Maxine ^f   Tate, Jill ^g  

^a ACT Pathology   (Australia)

^b UNIVERSITY OF CANBERRA   (Australia)

^c MELBOURNE PATHOLOGY   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e NORTHERN HOSPITAL   (Australia)

^f Aotea Pathology ^*  (New Zealand)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Evidence based; Harmonisation; Reference interval

Indexed keywords

ANALYTIC METHOD; ARTICLE; CLINICAL DECISION MAKING; CLINICAL LABORATORY; DATA BASE; DATA MINING; EVIDENCE BASED MEDICINE; LABORATORY TEST; PRIORITY JOURNAL; REFERENCE VALUE; STANDARD; AGE; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; MALE; SEX DIFFERENCE; STANDARDS; STATISTICS;

AGE FACTORS; CLINICAL LABORATORY TECHNIQUES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; REFERENCE VALUES; SEX FACTORS; STATISTICS AS TOPIC;

EID: 84901603030     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.10.021     Document Type: Article

References (64)

1. Schneider A.J. Some thoughts on normal, or standard, values in clinical medicine. Pediatrics 1960, 26:973-984.
2. Horn P.S., Pesce A.J. Reference intervals: an update. Clin Chim Acta 2003, 334:5-23.
3. Ceriotti F. Prerequisites for use of common reference intervals. Clin Biochem Rev 2007, 28:115-121.
4. Horn P. Reference intervals and clinical decision limits. Clinical chemistry theory analysis correlation 2010, 439-455. 5th ed. L.A. Kaplan, A.J. Pesce (Eds.).
5. Thygesen K., Alpert J.S., Jaffe A.S., et al. Third universal definition of myocardial infarction. Nat Rev Cardiol 2012, 9:620-633.
6. Jones G.R., Barker A., Tate J., Lim C.F., Robertson K. The case for common reference intervals. Clin Biochem Rev 2004, 25:99-104.
7. Clinical and Laboratory Standards Institute Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline. CLSI document C28-A3 2008, Clinical and Laboratory Standards Institute, Wayne, PA. Third ed.
8. Price C.P. Evidence-based laboratory medicine: supporting decision-making. Clin Chem 2000, 46:1041-1050.
9. Sackett D.L., Rosenberg W.M.C., Gray J.A.M., Haynes R.B., Richardson W.S. Evidence-based medicine: what it is and what it isn't. BMJ 1996, 312:71-72.
10. Horvath A.R., Watine J., Miko T.L. ISO 15189:2003 and evidence based laboratory medicine. eJIFCC 2004, 15. [http://www.ifcc.org/PDF/150412200407.pdf accessed 6 April 2013].
11. Ceriotti F., Hinzmann R., Panteghini M. Reference intervals: the way forward. Ann Clin Biochem 2009, 46:8-17.
12. Solberg H.E. International Federation of Clinical Chemistry (IFCC). Scientific Committee, Clinical Section. Expert Panel on Theory of Reference Values International Committee for Standardization in Haematology (ICSH), Standing Committee on Reference Values. Approved recommendation (1986) on the theory of reference values. Part 1. The concept of reference values. Clin Chim Acta 1987, 165:111-118.
13. Johnson A.M., Hyltoft Petersen P., Whicher J.T., Carlstrom A., MacLennan S. International Federation of Clinical Chemistry and Laboratory Medicine, Committee on Plasma Proteins. Reference intervals for serum proteins: similarities and differences between adult Caucasian and Asian Indian males in Yorkshire, UK. Clin Chem Lab Med 2004, 42:792-799.
14. Ichihara K., Itoh Y., Lam C.W., et al. Science Committee for the Asian-Pacific Federation of Clinical Biochemistry Sources of variation of commonly measured serum analytes in 6 Asian cities and consideration of common reference intervals. Clin Chem 2008, 54:356-365.
15. Ozarda Y., Ichihara K., Barth J.H., Klee G. Committee on Reference Intervals and Decision Limits (C-RIDL), International Federation for Clinical Chemistry and Laboratory Medicine. Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values. Clin Chem Lab Med 2013, 51:1027-1040.
16. Larsson A., Stridsberg M., Lind L. Reference values for fasting insulin in 75year old females and males. Clin Biochem 2013, 46:1125-1127.
17. A R S, Parameaswari P.J., Shanthi B., Revathy C., Parijatham B.O. The reference intervals for the haematological parameters in healthy adult population of Chennai, southern India. J Clin Diagn Res 2012, 6:1675-1680.
18. Tate J.R. Troponin revisited 2008: assay performance. Clin Chem Lab Med 2008, 46:1489-1500.
19. Tate J.R., Ferguson W., Bais R., Kostner K., Marwick T., Carter A. The determination of the 99th centile level for troponin assays in an Australian reference population. Ann Clin Biochem 2008, 45:275-288.
20. Uettwiller-Geiger D., Wu A.H., Apple F.S., et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002, 48:869-876.
21. Apple F.S., Quist H.E., Doyle P.J., Otto A.P., Murakami M.M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003, 49:1331-1336.
22. Apple F.S., Murakami M.M. Serum 99th percentile reference cutoffs for seven cardiac troponin assays. Clin Chem 2004, 50:1477-1479.
23. Apple F.S., Murakami M.A. Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays. Clin Chem 2007, 53:1558-1560.
24. Koerbin G., Tate J.R., Hickman P.E. Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population. Ann Clin Biochem 2010, 47:524-528.
25. Koerbin G., Abhayaratna W.P., Potter J.M., et al. The effect of careful population selection (coning) on the 99th percentiles for both hs-cTnT and hs-cTnI. Clin Biochem Aug 24 2013, 10.1016/j.clinbiochem.2013.08.004.
26. Thygesen K., Mair J., Katus H., et al. The Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010, 31:2197-2204.
27. Panteghini M. Traceability as a unique tool to improve standardization in laboratory medicine. Clin Biochem 2009, 42:236-240.
28. In vitro diagnostic medical devices - measurement of quantities in biological samples - metrological traceability of values assigned to calibrators and control materials ISO 17511 2003.
29. Medical laboratories - requirements for quality and competence 2012, [15189].
30. Jones G., Barker A. Standardisation of reference intervals: an Australasian view. Clin Biochem Rev 2007, 28:169-173.
31. Koerbin G. Common reference interval analytical issues [accessed 6/6/13]. http://www.aacb.asn.au/documents/item/381.
32. Tate J., Koerbin G., Ryan J., et al. The AACB workshop on harmonised reference limits - recommendations for adult reference intervals. Clin Biochem Rev 2012, 33:S40.
33. Jones G.R.D., Sikaris K., Gill J. Allowable limits of performance' for external quality assurance programs - an approach to application of the Stockholm Criteria by the RCPA Quality Assurance Programs. Clin Biochem Rev 2012, 133-139.
34. Kenny D., Fraser C.G., Hyltoft Petersen P., Kallner A. Strategies to set global analytical quality specifications in laboratory medicine - consensus agreement. Scand J Clin Lab Invest 1999, 59:585.
35. Sikaris K. Application of the Stockholm hierarchy to defining the quality of reference intervals and clinical decision limits. Clin Biochem Rev 2012, 33:141-148.
36. Ichihara K., Ozarda Y., Klee G., Straseski J., Baumann N., Ishikura K. Committee on Reference Intervals and Decision Limits, International Federation for Clinical Chemistry and Laboratory Medicine. Utility of a panel of sera for the alignment of test results in the worldwide multicenter study on reference values. Clin Chem Lab Med 2013, 51:1007-1025. 10.1515/cclm-2013-0248.
37. Harris E.K., Boyd J.C. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990, 36:265-270.
38. Clinical and Laboratory Standards Institute How to define and determine reference intervals in the clinical laboratory; approved guideline (CLSI document C28-A2) 2000, Clinical and Laboratory Standards Institute, PA, USA. 2nd ed.
39. Lahti A. Partitioning biochemical reference data into subgroups: comparison of existing methods. Clin Chem Lab Med 2004, 42:725-733.
40. Lahti A., Hyltoft Petersen P., Boyd J.C., Rustad P., Laake P., Solberg H.E. Partitioning of nongaussian distributed biochemical reference data into subgroups. Clin Chem 2004, 50:891-900.
41. Dixon W.J. Processing data for outliers. Biometrics 1953, 9:74-89.
42. Horn P.S., Feng L., Li Y., Pesce A.J. Effect of outliers and nonhealthy individuals on reference interval estimation. Clin Chem 2001, 47:2137-2145.
43. Kouri T., Kairisto V., Virtanen A., et al. Reference intervals developed from data for hospitalized patients: computerized method based on combination of laboratory and diagnostic data. Clin Chem 1994, 40:2209-2215.
44. Grossi E., Colombo R., Cavuto S., et al. The RELAB project: a new method for the formulation of reference intervals based on current data. Clin Chem 2005, 51:1232-1240.
45. Bock B.J., Dolan C.T., Miller G.C., et al. The data warehouse as a foundation for population-based reference intervals. Am J Clin Pathol 2003, 120:662-670.
46. Bhattacharya C.G. A simple method of resolution of a distribution into Gaussian components. Biometrics 1967, 23:115-135.
47. Jones G., Barker A. Reference intervals. Clin Biochem Rev 2008, 29-97.
48. Hoffmann R. Statistics in the practice of medicine. JAMA 1963, 185:864-873.
49. Hoffmann J.J.M.L., van den Broek N.M.A., Curvers J. Reference intervals of extended erythrocyte and reticulocyte parameters. Clin Chem Lab Med 2012, 50:941-948.
50. Barth J.H. Reference ranges need further clarity. Ann Clin Biochem 2009, 46:1-2.
51. Berg J., Lane V. Pathology harmony; a pragmatic and scientific approach to unfounded variation in the clinical laboratory. Ann Clin Biochem 2011, 48:195-197.
52. Rustad P., Felding P., Lahti A. Proposal for guidelines to establish common biological reference intervals in large geographical areas for biochemical quantities measured frequently in serum and plasma. Clin Chem Lab Med 2004, 42:783-791.
53. Hyltoft Petersen P., Rustad P. Prerequisites for establishing common reference intervals. Scand J Clin Lab Invest 2004, 64:285-292.
54. Rustad P., Felding P., Lahti A., Hyltoft Petersen P. Descriptive analytical data and consequences for calculation of common reference intervals in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 2004, 64:343-370.
55. Rustad P., Felding P., Franzson I., et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004, 64:271-284.
56. Ichihara K., Ceriotti F., Tam T.H., et al. The Asian project for collaborative derivation of reference intervals: (1) strategy and major results of standardized analytes. Clin Chem Lab Med 2013, 23:1-14.
57. Ichihara K., Ceriotti F., Kazuo M., et al. The Asian project for collaborative derivation of reference intervals: (2) results of non-standardized analytes and transference of reference intervals to the participating laboratories on the basis of cross-comparison of test results. Clin Chem Lab Med 2013, 23:1-15.
58. Tate J.R., Johnson R., Legg M. Harmonisation of laboratory testing. Clin Biochem Rev 2012, 33:81-84.
59. Plebani M. Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 2013, 51:741-751.
60. Legg M., Swanepoel C. The Australian pathology units and terminology standardization project - an overview. Clin Biochem Rev 2012, 33:103-108.
61. Position statement on lipid management-2005 National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Heart Lung Circ 2005, 14:275-291.
62. Pathology harmony [Accessed 18 June 2013]. http://www.pathologyharmony.co.uk.
63. Lo Y.C., Armbruster D.A. Reference intervals of common clinical chemistry analytes for adults in Hong Kong. eJIFCC 2012, [http://www.ifcc.org/ifcc-communications-publications-division(accessed 13 June 2013)].
64. Pagani F., Bonora R., Panteghini M. Reference interval for lactate dehydrogenase catalytic activity in serum measured according to the new IFCC recommendations. Clin Chem Lab Med 2003, 41:970-971.